News

Filter

Current filters:

None

37 to 46 of 98134 results

FDA safety review of Zyprexa Relprevv calls for no changes to current prescribing

24-03-2015

The US Food and Drug Administration has concluded a review of a study undertaken to determine the cause…

Eli LillyHealthcareNeurologicalPharmaceuticalRegulationUSAZyprexa Relprevv

Regenerative Medicine Expert Group publishes report with action plan for UK implementation

Regenerative Medicine Expert Group publishes report with action plan for UK implementation

24-03-2015

The Regenerative Medicine Expert Group has published its report ‘Building on our own potential: a UK…

BiotechnologyPricingRegulationResearchUK

97% of Australians want new cancer medicines subsidized through PBS

24-03-2015

New findings released by Newspoll shows overwhelming support for access to new cancer medicines through…

AustraliaFinancialHealthcareOncologyPharmaceutical

Novo Nordisk’s Saxenda gains EU approval for obesity

24-03-2015

There was good news for Danish diabetes care giant Novo Nordisk yesterday, when, late in the day, the…

DiabetesEuropeMetabolicsNovo NordiskPharmaceuticalRegulationSaxendaVictoza

Takeda in-licenses ImmunoGen’s antibody-drug conjugate technology

Takeda in-licenses ImmunoGen’s antibody-drug conjugate technology

23-03-2015

US biotech firm ImmunoGen (Nasdaq: IMGN) saw its shares leap 17% to $8.74 in early morning trading on…

BiotechnologyImmunoGenLicensingOncologyTakeda Pharmaceutical

Pfizer and Lilly gear up to resume Phase III chronic pain program for tanezumab

23-03-2015

US pharma majors Pfizer and Eli Lilly both saw their shares rise in pre-market trading today, as they…

Eli LillyLicensingNeurologicalPfizerPharmaceuticalRegulationUSA

GenVec collaborates with TheraBiologics on cancer therapeutics

GenVec collaborates with TheraBiologics on cancer therapeutics

23-03-2015

Gene therapy specialist GenVec has formed a collaboration with TheraBiologics to develop cancer therapeutics.

BiotechnologyGenVecOncologyResearchUSA

Biogen Idec rebrands as Biogen with new logo

Biogen Idec rebrands as Biogen with new logo

23-03-2015

US biotech firm Biogen Idec has rebranded as Biogen, introducing a new logo and corporate identity.

BiogenBiotechnologyBusiness FinanceIDECManagementUnited StatesUSA

Pfenex gets early HSR clearance for collaboration with Hospira

23-03-2015

The US Federal Trade Commission has granted early termination of the waiting period under the Hart-Scott-Rodino…

BiosimilarsBiotechnologyGenentechHospiraLicensingLucentisOphthalmicsPF582PfenexRegulationRocheUSA

37 to 46 of 98134 results

Back to top